Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Classification and Identification01:28

Methods of Classification and Identification

344
Bacterial identification relies on a diverse array of techniques to classify and understand microorganisms, each tailored to uncover specific characteristics. Traditional morphological approaches, while still valuable, are limited for closely related or structurally simple organisms. Modern methods integrate biochemical, serological, genetic, and advanced molecular tools to achieve greater accuracy.Morphological and Biochemical TechniquesMorphological characteristics, such as cell shape and...
344
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

283
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
283

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid Bacteria Identification and Antimicrobial Susceptibility Testing via 5-Min Fluorescence In Situ Hybridization.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

An update on novel taxa and revised taxonomic status of bacteria isolated from human clinical specimens described in 2024.

Journal of clinical microbiology·2025
Same author

Multicenter evaluation of blood culture contamination and blood cultures practices in US acute care hospitals: time for standardization.

Journal of clinical microbiology·2025
Same author

Evaluation of long-read 16S rRNA next-generation sequencing for identification of bacterial isolates in a clinical diagnostic laboratory.

Journal of clinical microbiology·2025
Same author

Blood Culture Use in Medical and Surgical Intensive Care Units and Wards.

JAMA network open·2025
Same author

Correction for Sulaiman et al., "The Brief Case: A fatal case of <i>Legionella pneumophila</i> in an elderly patient".

Journal of clinical microbiology·2025
Same journal

Use of gloves: current evidence vs. current use.

Current opinion in infectious diseases·2026
Same journal

Understanding challenges to prevention of healthcare related infections.

Current opinion in infectious diseases·2026
Same journal

Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.

Current opinion in infectious diseases·2026
Same journal

Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients.

Current opinion in infectious diseases·2026
Same journal

Dengue and chikungunya vaccines past, present and future: implications for travelers.

Current opinion in infectious diseases·2026
Same journal

Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

Current opinion in infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Oct 20, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K

The future of Clostridioides difficile diagnostics.

Masako Mizusawa1, Karen C Carroll2

  • 1Section of Infectious Diseases, Department of Internal Medicine, University of Missouri, Kansas City, Missouri.

Current Opinion in Infectious Diseases
|September 15, 2021
PubMed
Summary
This summary is machine-generated.

Diagnosing Clostridioides difficile (C. diff) disease requires a shift from rapid molecular tests to algorithmic approaches including toxin detection. Future strategies focus on ultrasensitive tests, biomarkers, and microbiome analysis for improved C. diff diagnosis.

More Related Videos

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.2K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.8K

Related Experiment Videos

Last Updated: Oct 20, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.2K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.8K

Area of Science:

  • Clinical microbiology and infectious diseases.
  • Diagnostic test development and validation.
  • Microbiome research and metabolomics.

Background:

  • Clostridioides difficile (C. diff) remains a significant cause of morbidity and mortality, despite epidemiological shifts.
  • Accurate and timely diagnosis is crucial for effective patient management and infection control.

Purpose of the Study:

  • To review current and future diagnostic strategies for C. diff disease.
  • To highlight advancements in testing methodologies and diagnostic stewardship.

Main Methods:

  • Analysis of recent prospective studies on C. diff diagnostic testing.
  • Evaluation of algorithmic diagnostic approaches incorporating toxin detection.
  • Review of emerging technologies, including ultrasensitive toxin assays and novel biomarkers.
  • Exploration of microbiome research for novel diagnostic markers.

Main Results:

  • No single diagnostic test is optimal for all C. diff cases.
  • Algorithmic approaches combining molecular tests with toxin detection are recommended.
  • Diagnostic stewardship improves the utilization of molecular C. diff tests.
  • Ultrasensitive toxin tests and new biomarkers show promise for improved specificity.

Conclusions:

  • Current focus is on optimizing test utilization and developing advanced diagnostic tools.
  • Future diagnostic approaches may integrate improved toxin testing, predictive biomarkers, and metabolomic analysis.
  • Leveraging microbiome research offers potential for novel C. diff detection methods.